Cargando…
GLUT4-overexpressing engineered muscle constructs as a therapeutic platform to normalize glycemia in diabetic mice
Skeletal muscle insulin resistance is a main defect in type 2 diabetes (T2D), which is associated with impaired function and content of glucose transporter type 4 (GLUT4). GLUT4 overexpression in skeletal muscle tissue can improve glucose homeostasis. Therefore, we created an engineered muscle const...
Autores principales: | Beckerman, Margarita, Harel, Chava, Michael, Inbal, Klip, Amira, Bilan, Philip J., Gallagher, Emily J., LeRoith, Derek, Lewis, Eli C., Karnieli, Eddy, Levenberg, Shulamit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514095/ https://www.ncbi.nlm.nih.gov/pubmed/34644106 http://dx.doi.org/10.1126/sciadv.abg3947 |
Ejemplares similares
-
Effect of Case-Based Training for Medical Residents on Inpatient Glycemia
por: Tamler, Ronald, et al.
Publicado: (2011) -
Overexpression of the scopoletin biosynthetic pathway enhances lignocellulosic biomass processing
por: Hoengenaert, Lennart, et al.
Publicado: (2022) -
Myosin Va mediates Rab8A-regulated GLUT4 vesicle exocytosis in insulin-stimulated muscle cells
por: Sun, Yi, et al.
Publicado: (2014) -
A complex of Rab13 with MICAL-L2 and α-actinin-4 is essential for insulin-dependent GLUT4 exocytosis
por: Sun, Yi, et al.
Publicado: (2016) -
Overexpression of Nfe2l1 increases proteasome activity and delays vision loss in a preclinical model of human blindness
por: Wang, Yixiao, et al.
Publicado: (2023)